Ads
    Related paper
  1. PROGNOSTIC VALUE OF NATRIURETIC PEPTIDES IN RISK ASSESSMENT OF VENTRICULAR ARRHYTHMIAS IN PATIENTS WITH HEART FAILURE AND ATRIAL FIBRILLATION
  2. RELATIONSHIP OF THE POLYMORPHIC VARIANT RS989692 OF THE NEPRILYSIN GENE (MME) WITH THE LEVELS OF NATRIURETIC PEPTIDES AND ITS CLINICAL SIGNIFICANCE IN PATIENTS WITH HEART FAILURE AND ATRIAL FIBRILLATION
  3. Frequency of risk factors of cardiovascular diseases and renal functional state in patients with chronic heart failure with atrial fibrillation
  4. Clinical course and risk prediction of permanent atrial fibrillation development in patients with chronic heart failure and mid-range ejection fraction of the left ventricle
  5. Atrial Fibrillation in Patients after Myocardial Infarction: Association with Changes in Heart Structure, Heart Failure and Age
  6. EXPERIENCE OF MANAGEMENT OF THE PATIENT WITH THE RESYNCHRONIZATION BIVENTRICULAR PACING WITHOUT DESTRUCTION OF ATRIO-VENTRICULAR NODE SUFFERING FROM CHRONIC HEART FAILURE AND PERMANENT ATRIAL FIBRILLATION
  7. Left Ventricular Myocardial Remodeling among Patients with Ischemic Heart Disease Combined with Hypertension and Persistent Atrial Fibrillation
  8. CLINICAL AND INSTRUMENTAL CHARACTERISTICS OF HEART FAILURE IN PATIENTS WITH DIFFERENT FORMS OF ATRIAL FIBRILLATION
  9. FUNCTION CLASS OF CHRONIC HEART FAILURE AND EFFICIENCY OF THERAPY AMIODARONE AND ITS COMBINATION WITH BETA-ADRENOBLOCKERS PERMANENT FORM OF ATRIAL FIBRILLATION AT PATIENTS WITH ARTERIAL HYPERTENSION AND ISCHEMIC HEART DISEASE
  10. VENTRICULAR RATE AND BLOOD PRESSURE ORTHOSTATIC REACTIONS IN PATIENTS WITH PERMANENT ATRIAL FIBRILLATION IN GENERAL CARDIOVASCULAR RISK GROUPS